Latest Stories
Recent Stories
LAS VEGAS, Nov. 11, 2026 /PRNewswire/ -- Following its successful global release earlier this fall, Olight brought its acclaimed Oclip 2 Series to the 2026 SEMA Show in Las Vegas (Nov. 3–6), targeting automotive technicians, mechanics, and inspectors who demand compact, versatile, hands-free…
Plainwell, MI / Storyteller / Nov 11, 2026 /
New York, NY / Storyteller / Nov 11, 2026 /
Albany, New York / Storyteller / Nov 11, 2026 /
Sarasota, FL / Storyteller / Nov 11, 2026 /
Metairie, LA / Storyteller / Nov 11, 2026 /
LAWRENCEVILLE, GA / Storyteller / Nov 11, 2026 /
Cornelius, NC / Storyteller / Nov 11, 2026 /
Toronto pest and wildlife control company adds 50 reviews since July, following its HomeStars Best Of award, SPMAO membership and BBB accreditation.
Charlotte, NC / Storyteller / Nov 11, 2026 /
Seattle, WA / Storyteller / Nov 11, 2026 /
New York, NY / Storyteller / Nov 11, 2026 /
New York, NY / Storyteller / Nov 11, 2026 /
Scott Keever Releases White Paper Analyzing the Impact of Negative Media Coverage on Executive Search Visibility and Online Reputation
New Research Boulevard center brings SAT and ACT test prep, academic tutoring, and college admission essay support to families in Northwest Austin.
Freeport's family-owned jeweler wins the Jewelry Store category of the 2026 Best of the Region Community's Choice Awards, decided by public vote
The Korean makeup brand, with more than 7 million units sold since 2017, brings seven shades of its signature eye pencil and four shades of its cream stick shadow to U.S. shoppers.
SAN DIEGO, Nov. 11, 2026 /PRNewswire/ -- Sempra (NYSE: SRE) today announced that its board of directors has declared a $0.6575 per share quarterly dividend on the company's common stock, which is payable Jan. 15, 2027, to common stock shareholders of record at the close of business on Dec. 1…
PALO ALTO, Calif., Nov. 11, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced that Victor Perlroth, M.D., Chief Executive Officer,…
